File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.antiviral.2011.07.011
- Scopus: eid_2-s2.0-79961104264
- PMID: 21798291
- WOS: WOS:000294936800015
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro
Title | Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||||
Keywords | Antiviral H5N1 Influenza Selective COX-2 inhibitor | ||||||||||
Issue Date | 2011 | ||||||||||
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/antiviral | ||||||||||
Citation | Antiviral Research, 2011, v. 91 n. 3, p. 330-334 How to Cite? | ||||||||||
Abstract | A selective cyclooxygenase-2 (COX-2) inhibitor has been previously shown to suppress the hyper-induced pro-inflammatory responses in H5N1 infected primary human cells. Here, we demonstrate that COX-2 inhibitors suppress H5N1 virus replication in human macrophages suggesting that H5N1 virus replication (more so than seasonal H1N1 virus) is dependent on activation of COX-2 dependent signaling pathways in host cells. COX-2 and its downstream signaling pathways deserve detailed investigation as a novel therapeutic target for treatment of H5N1 disease. © 2011 Elsevier B.V. | ||||||||||
Persistent Identifier | http://hdl.handle.net/10722/141717 | ||||||||||
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 1.500 | ||||||||||
ISI Accession Number ID |
Funding Information: This work was supported by research grants from Canadian Institutes of Health Research (Reference No.: TPA-90195), Research Fund for Control of Infectious Diseases (Grant 06060562 to S.M.Y.L.), Research Grants Council (Grant HKU 773707M to J.S.M.P.) and AoE Funding (AoE/M-12/06) from the Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government. We thank K.P. Mok, Department of Microbiology, The University of Hong Kong for providing the H9N2 virus strain used in this study. | ||||||||||
References | |||||||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, SMY | en_HK |
dc.contributor.author | Gai, WW | en_HK |
dc.contributor.author | Cheung, TKW | en_HK |
dc.contributor.author | Peiris, JSM | en_HK |
dc.date.accessioned | 2011-09-27T02:59:03Z | - |
dc.date.available | 2011-09-27T02:59:03Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Antiviral Research, 2011, v. 91 n. 3, p. 330-334 | en_HK |
dc.identifier.issn | 0166-3542 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/141717 | - |
dc.description.abstract | A selective cyclooxygenase-2 (COX-2) inhibitor has been previously shown to suppress the hyper-induced pro-inflammatory responses in H5N1 infected primary human cells. Here, we demonstrate that COX-2 inhibitors suppress H5N1 virus replication in human macrophages suggesting that H5N1 virus replication (more so than seasonal H1N1 virus) is dependent on activation of COX-2 dependent signaling pathways in host cells. COX-2 and its downstream signaling pathways deserve detailed investigation as a novel therapeutic target for treatment of H5N1 disease. © 2011 Elsevier B.V. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/antiviral | en_HK |
dc.relation.ispartof | Antiviral Research | en_HK |
dc.subject | Antiviral | en_HK |
dc.subject | H5N1 | en_HK |
dc.subject | Influenza | en_HK |
dc.subject | Selective COX-2 inhibitor | en_HK |
dc.subject.mesh | Cyclooxygenase 2 - genetics - metabolism | - |
dc.subject.mesh | Influenza A Virus, H5N1 Subtype - drug effects - physiology | - |
dc.subject.mesh | Influenza, Human - drug therapy - virology | - |
dc.subject.mesh | Macrophages - cytology - drug effects - virology | - |
dc.subject.mesh | Signal Transduction - drug effects | - |
dc.title | Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Lee, SMY: suki@hku.hk | en_HK |
dc.identifier.email | Peiris, JSM: malik@hkucc.hku.hk | en_HK |
dc.identifier.authority | Lee, SMY=rp01536 | en_HK |
dc.identifier.authority | Peiris, JSM=rp00410 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.antiviral.2011.07.011 | en_HK |
dc.identifier.pmid | 21798291 | - |
dc.identifier.scopus | eid_2-s2.0-79961104264 | en_HK |
dc.identifier.hkuros | 204662 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-79961104264&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 91 | en_HK |
dc.identifier.issue | 3 | en_HK |
dc.identifier.spage | 330 | en_HK |
dc.identifier.epage | 334 | en_HK |
dc.identifier.eissn | 1872-9096 | - |
dc.identifier.isi | WOS:000294936800015 | - |
dc.publisher.place | Netherlands | en_HK |
dc.relation.project | Effector roles of cytokine cascades in the pathogenesis of human H5N1 disease | - |
dc.relation.project | Control of Pandemic and Inter-pandemic Influenza | - |
dc.relation.project | Role of cyclooxygenase-2 (COX-2) influenza A (subtype H5N1) viral pathogenesis and the potential use of its inhibitors for the therapy of H5N1 disease | - |
dc.identifier.scopusauthorid | Lee, SMY=35435155600 | en_HK |
dc.identifier.scopusauthorid | Gai, WW=45661364100 | en_HK |
dc.identifier.scopusauthorid | Cheung, TKW=16229531100 | en_HK |
dc.identifier.scopusauthorid | Peiris, JSM=7005486823 | en_HK |
dc.identifier.citeulike | 9647356 | - |
dc.identifier.issnl | 0166-3542 | - |